| Peripheral whole blood microRNA alterations in major depression and bipolar disorder E Maffioletti, A Cattaneo, G Rosso, G Maina, C Maj, M Gennarelli, ... Journal of affective disorders 200, 250-258, 2016 | 171 | 2016 |
| Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes U Albert, G Rosso, G Maina, F Bogetto Journal of affective disorders 105 (1-3), 297-303, 2008 | 155 | 2008 |
| Stressful life events and obsessive–compulsive disorder: clinical features and symptom dimensions G Rosso, U Albert, GF Asinari, F Bogetto, G Maina Psychiatry research 197 (3), 259-264, 2012 | 127 | 2012 |
| Serum levels of brain-derived neurotrophic factor in drug-naive obsessive–compulsive patients: a case–control study G Maina, G Rosso, R Zanardini, F Bogetto, M Gennarelli, ... Journal of affective disorders 122 (1-2), 174-178, 2010 | 126 | 2010 |
| A systematic review of evidence-based treatment strategies for obsessive-compulsive disorder resistant to first-line pharmacotherapy U Albert, D Marazziti, G Di Salvo, F Solia, G Rosso, G Maina Current medicinal chemistry 25 (41), 5647-5661, 2018 | 88 | 2018 |
| Duration of untreated illness and response to SRI treatment in obsessive-compulsive disorder U Albert, F Barbaro, S Bramante, G Rosso, D De Ronchi, G Maina European Psychiatry 58, 19-26, 2019 | 77 | 2019 |
| Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women G Maina, G Rosso, A Aguglia, F Bogetto Archives of women's mental health 17, 367-372, 2014 | 66 | 2014 |
| Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study G Maina, U Albert, G Rosso, F Bogetto Journal of Clinical Psychiatry 69 (4), 609, 2008 | 58 | 2008 |
| Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results G Maina, G Rosso, F Bogetto Journal of Affective Disorders 114 (1-3), 200-207, 2009 | 57 | 2009 |
| Agespecific prevalence of metabolic syndrome in Italian patients with bipolar disorder V Salvi, V D'Ambrosio, G Rosso, F Bogetto, G Maina Psychiatry and clinical neurosciences 65 (1), 47-54, 2011 | 53 | 2011 |
| Prevalence and correlates of vitamin D deficiency in a sample of 290 inpatients with mental illness A Cuomo, G Maina, S Bolognesi, G Rosso, B Beccarini Crescenzi, ... Frontiers in psychiatry 10, 167, 2019 | 52 | 2019 |
| No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression G Maina, G Rosso, S Rigardetto, S Chiadò Piat, F Bogetto Psychotherapy and Psychosomatics 79 (5), 295-302, 2010 | 51 | 2010 |
| Real-world experience of esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study) G Martinotti, A Vita, A Fagiolini, G Maina, A Bertolino, B Dell'Osso, ... Journal of Affective Disorders 319, 646-654, 2022 | 49 | 2022 |
| Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes K Heerlein, G Perugi, C Otte, T Frodl, G Degraeve, W Hagedoorn, ... Journal of Affective Disorders 290, 334-344, 2021 | 48 | 2021 |
| The efficacy of adding short-term psychodynamic psychotherapy to antidepressants in the treatment of depression: A systematic review and meta-analysis of individual participant … E Driessen, JJM Dekker, J Peen, HL Van, G Maina, G Rosso, S Rigardetto, ... Clinical psychology review 80, 101886, 2020 | 43 | 2020 |
| The microbiome: A new target for research and treatment of schizophrenia and its resistant presentations? A systematic literature search and review A Cuomo, G Maina, G Rosso, B Beccarini Crescenzi, S Bolognesi, ... Frontiers in Pharmacology 9, 1040, 2018 | 42 | 2018 |
| Glucose metabolism alterations in patients with bipolar disorder G Rosso, A Cattaneo, R Zanardini, M Gennarelli, G Maina, ... Journal of affective disorders 184, 293-298, 2015 | 41 | 2015 |
| Axis II comorbidity in euthymic bipolar disorder patients: no differences between bipolar I and II subtypes G Rosso, U Albert, F Bogetto, G Maina Journal of affective disorders 115 (1-2), 257-261, 2009 | 40 | 2009 |
| Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatmentresistant … G Martinotti, B Dell'Osso, G Di Lorenzo, G Maina, A Bertolino, M Clerici, ... Bipolar disorders 25 (3), 233-244, 2023 | 39 | 2023 |
| Using sertraline in postpartum and breastfeeding: balancing risks and benefits A Cuomo, G Maina, SM Neal, G De Montis, G Rosso, S Scheggi, ... Expert opinion on drug safety 17 (7), 719-725, 2018 | 37 | 2018 |
